Clinical Trial Update: DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of a DPP-4 inhibitor on serum BNP levels in diabetic patients with congestive heart failure; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: Mitsui Memorial Hospital | Conditions: Heart Failure, Diabetes Mellitus | Phase 4 | Status: COMPLETED